Pharmacokinetic and pharmacodynamic aspects of antibiotic use in high-risk populations

被引:22
作者
Bergman, Scott J. [1 ]
Speil, Cristian
Short, Michael
Koirala, Janak
机构
[1] So Illinois Univ, Sch Pharm, Dept Pharm Practice, Edwardsville, IL 62026 USA
[2] So Illinois Univ, Sch Med, Div Infect Dis, Springfield, IL USA
[3] Mem Med Ctr, Dept Pharm Serv, Springfield, IL 62781 USA
关键词
D O I
10.1016/j.idc.2007.07.004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The study of pharmacokinetics includes the absorption, distribution, metabolism, and elimination of drugs. The pharmacologic effect that a medication has on the body is known as pharmacodynamics. With antimicrobials, pharmacokinetic and pharmacodynamic parameters become especially important because of the association between host drug concentrations, microorganism eradication, and resistance. This article focuses on the pharmacokinetic changes that can occur with antimicrobials when they are used in patients at high risk of infections and how they influence pharmacodynamic effects. The populations described here include patients with obesity and diabetes mellitus, renal or hepatic failure, chronic lung disease, severe burns, and long-term prosthetic devices and the elderly.
引用
收藏
页码:821 / +
页数:27
相关论文
共 146 条
[81]   Mechanisms of biofilm resistance to antimicrobial agents [J].
Mah, TFC ;
O'Toole, GA .
TRENDS IN MICROBIOLOGY, 2001, 9 (01) :34-39
[82]  
Mandell G. L., MANDELL DOUGLAS BENN
[83]   ABSORPTION OF CIPROFLOXACIN IN PATIENTS WITH DIABETIC GASTROPARESIS [J].
MARANGOS, MN ;
SKOUTELIS, AT ;
NIGHTINGALE, CH ;
ZHU, Z ;
PSYROGIANNIS, AG ;
NICOLAU, DP ;
BASSARIS, HP ;
QUINTILIANI, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (09) :2161-2163
[84]   PHARMACOKINETICS OF AZITHROMYCIN IN PATIENTS WITH IMPAIRED HEPATIC-FUNCTION [J].
MAZZEI, T ;
SURRENTI, C ;
NOVELLI, A ;
CRISPO, A ;
FALLANI, S ;
CARLA, V ;
SURRENTI, E ;
PERITI, P .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1993, 31 :57-63
[85]   Antibiotic use in the elderly: Issues and nonissues [J].
McCue, JD .
CLINICAL INFECTIOUS DISEASES, 1999, 28 (04) :750-752
[86]   Pharmacokinetic and pharmacodynamic issues in the treatment of bacterial infectious diseases [J].
McKinnon, PS ;
Davis, SL .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2004, 23 (04) :271-288
[87]   Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections [J].
Moise-Broder, PA ;
Forrest, A ;
Birmingham, MC ;
Schentag, JJ .
CLINICAL PHARMACOKINETICS, 2004, 43 (13) :925-942
[88]   PHARMACOKINETICS OF FLUOROQUINOLONES IN HEPATIC-FAILURE [J].
MONTAY, G ;
GAILLOT, J .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1990, 26 :61-67
[89]   THE ASSOCIATION OF AMINOGLYCOSIDE PLASMA-LEVELS WITH MORTALITY IN PATIENTS WITH GRAM-NEGATIVE BACTEREMIA [J].
MOORE, RD ;
SMITH, CR ;
LIETMAN, PS .
JOURNAL OF INFECTIOUS DISEASES, 1984, 149 (03) :443-448
[90]   RISK-FACTORS FOR NEPHROTOXICITY IN PATIENTS TREATED WITH AMINOGLYCOSIDES [J].
MOORE, RD ;
SMITH, CR ;
LIPSKY, JJ ;
MELLITS, ED ;
LIETMAN, PS .
ANNALS OF INTERNAL MEDICINE, 1984, 100 (03) :352-357